Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 1032 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

1,032 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,032 programs

Clinical programs

Page 2 of 22

  1. Coenzyme Q10 and Lisinopril

    United Therapeutics Europe Ltd

    Duchenne Muscular Dystrophy

    phase 3 small molecule completed

    1 trial

  2. Cold Stored Platelets

    United Therapeutics Europe Ltd

    Acute Blood Loss

    phase 3 mab completed

    1 trial

  3. D-cycloserine

    United Therapeutics Europe Ltd

    Autistic Disorder

    phase 3 small molecule completed

    1 trial

  4. DCS (D-Cycloserine ) + Prolonged Imaginal Exposure

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder

    phase 3 small molecule completed

    1 trial

  5. Dexamethasone

    United Therapeutics Europe Ltd

    Shoulder Pain

    phase 3 small molecule terminated

    1 trial

  6. Dinutuximab

    United Therapeutics Europe Ltd

    Small Cell Lung Cancer

    phase 3 mab completed

    1 trial

  7. Direct-Acting Oral Anticoagulants (used as per local standard practice)

    United Therapeutics Europe Ltd

    Traumatic Intracranial Haemorrhage

    phase 3 small molecule active

    1 trial

  8. Distress Thermometer and Problems List

    United Therapeutics Europe Ltd

    Cancer

    phase 3 other completed

    1 trial

  9. Dose

    United Therapeutics Europe Ltd

    Chronic Migraine, Headache

    phase 3 small molecule terminated

    1 trial

  10. Doxycycline

    United Therapeutics Europe Ltd

    Lymphedema

    phase 3 small molecule completed

    3 trials

  11. Doxycycline (200mg/day) or Placebo

    United Therapeutics Europe Ltd

    Persian Gulf Syndrome

    phase 3 small molecule completed

    1 trial

  12. Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment

    United Therapeutics Europe Ltd

    COVID19

    phase 3 small molecule active

    1 trial

  13. Educational Dementia training

    United Therapeutics Europe Ltd

    Dementia

    phase 3 other active

    1 trial

  14. Educational Intervention

    United Therapeutics Europe Ltd

    Hematologic Malignancies

    phase 3 other active

    1 trial

  15. Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    phase 3 mab completed

    1 trial

  16. Empagliflozin 10 mg

    United Therapeutics Europe Ltd

    Acute Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  17. Endoscopic submucosal dissection

    United Therapeutics Europe Ltd

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  18. Enhanced standard management

    United Therapeutics Europe Ltd

    Pacemaker Complication

    phase 3 other active

    1 trial

  19. Erenumab

    United Therapeutics Europe Ltd

    Fibromyalgia

    phase 3 small molecule terminated

    1 trial

  20. Eribulin Mesylate

    United Therapeutics Europe Ltd

    Breast Adenocarcinoma

    phase 3 small molecule on hold

    1 trial

  21. Everolimus

    United Therapeutics Europe Ltd

    Pediatric Heart Transplantation

    phase 3 small molecule active

    1 trial

  22. Exoskeletal assisted walking

    United Therapeutics Europe Ltd

    Spinal Cord Injuries

    phase 3 other active

    1 trial

  23. Expressive Writing

    United Therapeutics Europe Ltd

    Posttraumatic Stress Disorder

    phase 3 other completed

    1 trial

  24. Extensively Hydrolyzed formula

    United Therapeutics Europe Ltd

    Cow Milk Allergy

    phase 3 other completed

    1 trial

  25. Farletuzumab

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  26. Gardasill 9™ vaccine

    United Therapeutics Europe Ltd

    Neoplasia

    phase 3 mab completed

    1 trial

  27. Glycerin Suppository

    United Therapeutics Europe Ltd

    Encopresis

    phase 3 small molecule completed

    1 trial

  28. H.22.03.01.09.A2

    United Therapeutics Europe Ltd

    Mortality Through Six Months of Age

    phase 3 other completed

    1 trial

  29. Home non-invasive ventilation

    United Therapeutics Europe Ltd

    Hypercapnic Respiratory Failure

    phase 3 other completed

    1 trial

  30. Hormonal Contraception

    United Therapeutics Europe Ltd

    Pregnancy

    phase 3 small molecule completed

    1 trial

  31. Hormone replacement therapy (estrogen/progestin)

    United Therapeutics Europe Ltd

    Anorexia Nervosa

    phase 3 small molecule completed

    1 trial

  32. Household-based water treatment with NADCC tablets

    United Therapeutics Europe Ltd

    Diarrhoea

    phase 3 other completed

    1 trial

  33. IL-1Ra

    United Therapeutics Europe Ltd

    Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

  34. ITDCVC98

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule completed

    1 trial

  35. Imatinib

    United Therapeutics Europe Ltd

    Myeloid Leukemia, Chronic, Chronic Phase

    phase 3 small molecule completed

    1 trial

  36. Imiquimod

    United Therapeutics Europe Ltd

    Cervical Intraepithelial Neoplasia

    phase 3 small molecule completed

    1 trial

  37. Immunoglobulins, Intravenous (Privigen)

    United Therapeutics Europe Ltd

    Encephalitis

    phase 3 small molecule completed

    1 trial

  38. In-person Cognitive Behavioral Therapy of Insomnia

    United Therapeutics Europe Ltd

    Insomnia

    phase 3 other completed

    1 trial

  39. Inhaled Treprostinil

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule active

    1 trial

  40. Inhaled treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule active

    5 trials

  41. Inhaled treprostinil solution

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule terminated

    2 trials

  42. Intervention - a validated home BP monitor and support from the specialist nurse

    United Therapeutics Europe Ltd

    Stroke

    phase 3 other completed

    1 trial

  43. Iron (27 mg) - folic acid (600 ug)

    United Therapeutics Europe Ltd

    Infant Mortality

    phase 3 other completed

    1 trial

  44. Isoniazid with Ethambutol

    United Therapeutics Europe Ltd

    Human Immunodeficiency Virus

    phase 3 small molecule completed

    1 trial

  45. KALOMIN™ Tab.

    United Therapeutics Europe Ltd

    Acute Bronchitis

    phase 3 small molecule completed

    1 trial

  46. Ketamine

    United Therapeutics Europe Ltd

    Chronic Pain

    phase 3 small molecule completed

    1 trial

  47. Ketamine Hydrochloride

    United Therapeutics Europe Ltd

    Traumatic Injury

    phase 3 small molecule active

    1 trial

  48. Khalas dates

    United Therapeutics Europe Ltd

    Diabetes Mellitus

    phase 3 other completed

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.